Clinical trial
FCM Versus R-FCM Followed by R-Maintenance or Observation Only
NCT00317096 · Ludwig-Maximilians - University of Munich, Other · Unknown status
Key facts
| NCT number | NCT00317096 |
|---|---|
| Title | FCM Versus R-FCM Followed by R-Maintenance or Observation Only |
| Official title | Treatment of Relapsed CBCC, CC and LPIC Lymphoma With FCM Chemotherapy Alone or in Combination With the Monoclonal Anti CD 20 Antibody Rituximab Followed by Anti-CD 20 Maintenance or Observation Only |
| Lead sponsor | Ludwig-Maximilians - University of Munich, Other |
| Status | Unknown status |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Lymphoma, Follicular, Low-Grade, Intermediate-Grade |
| Intervention type | Drug, Other, Procedure |
| Interventions | FCM, R-FCM, rituximab maintenance, observation only |
| Enrollment | 319 |
| Start date | Nov 1, 1998 |
| Primary completion | Jun 1, 2001 |
| Completion | Jun 1, 2021 |
| First posted | Apr 24, 2006 |
| Last update posted | May 7, 2021 |
| Countries | Germany |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: